PD-1 Blockade in Tumors with Mismatch-Repair Deficiency.

作者:

DOI: 10.1056/NEJMC1510353

关键词: AntibodyPd 1 blockadeCancer researchDNA mismatch repairMISMATCH REPAIR DEFICIENCYMonoclonalMedicineProgrammed Cell Death 1 Receptor

摘要:

参考文章(3)
Feriyl Bhaijee, Thomas Huebner, Ralph H. Hruban, Laura D. Wood, Nathan Cuka, Drew M. Pardoll, Nickolas Papadopoulos, Kenneth W. Kinzler, Shibin Zhou, Toby C. Cornish, Janis M. Taube, Robert A. Anders, James R. Eshleman, Bert Vogelstein, Luis A. Diaz, Dung T. Le, Jennifer N. Uram, Hao Wang, Bjarne R. Bartlett, Holly Kemberling, Aleksandra D. Eyring, Andrew D. Skora, Brandon S. Luber, Nilofer S. Azad, Dan Laheru, Barbara Biedrzycki, Ross C. Donehower, Atif Zaheer, George A. Fisher, Todd S. Crocenzi, James J. Lee, Steven M. Duffy, Richard M. Goldberg, Albert de la Chapelle, Minori Koshiji, PD-1 Blockade in Tumors with Mismatch-Repair Deficiency The New England Journal of Medicine. ,vol. 372, pp. 2509- 2520 ,(2015) , 10.1056/NEJMOA1500596
Eric Tu, Pei Zhi Cheryl Chia, Wanjun Chen, TGFβ in T cell biology and tumor immunity: Angel or devil? Cytokine & Growth Factor Reviews. ,vol. 25, pp. 423- 435 ,(2014) , 10.1016/J.CYTOGFR.2014.07.014
S Markowitz, J Wang, L Myeroff, R Parsons, L Sun, J Lutterbaugh, R. Fan, E Zborowska, K. Kinzler, B Vogelstein, al. et, Inactivation of the Type II TGF-β Receptor in Colon Cancer Cells with Microsatellite Instability Science. ,vol. 268, pp. 1336- 1338 ,(1995) , 10.1126/SCIENCE.7761852